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 INTRODUCTION 
 
                           Interstitial lung diseases is a term given to a heterogeneous group 
of clinical entities that share the following features: dyspnea, hypoxemia, 
restrictive ventilatory defect and the presence of bilateral diffuse 
pulmonary infiltrates on the chest roentgenograms1. It is now recently 
called by the term Diffuse Parenchymal lung diseases (DPLD) which is 
now on an increase. 
 
                The reason for that is the increased awareness, thorough history 
evaluation and the lot of incoming trials in the field of investigating 
modality. The disease is characterized by deteriorating parenchymal 
fibrosis and gas exchange. It remains innocuous in the early stage as 
most of the rheumatic patients have restricted mobility manifesting with 
subtle or nil pulmonary symptoms. Hence respiratory physician should be 
prudential in diagnosing the cases as early as possible. 
 
                      This study throws light on the semi invasive procedures on  
clinically and radiologically diagnosed cases rather than the invasive 
procedures. Since most of the patients denies procedures like surgical or 
transbronchial lung biopsies as well as they are in real respiratory  
 
           compromise, it is better to opt an alternative procedure. Bronchoalveolar 
lavage and pulmonary function test are frequently done nowadays as an 
adjunct to aid the diagnosis. 
 
The extent and pattern of the lesion in the High resolution 
computerized tomography is described in detail and its severity is 
identified based on the correlation with  PFT (Pulmonary function tests) 
and cellularity of the Bronchoalveolar lavage fluid. To enhance the 
knowledge in this area, statistical analysis is performed. This highlights the 
agreement as well as discordance between the variables. 
 
 
 
 
 
 
 
 
 
 
 
  
AIM OF THE STUDY 
 
To quantify the extent and severity of the interstitial lung disease as 
depicted in High Resolution computerized tomography.   
 
To study the relationship between the radiological patterns of 
Interstitial lung diseases with functional parameter (Forced vital capacity) 
and the cellularity of bronchoalveolar lavage fluid in patients with collagen 
vascular diseases. 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
                
                                Interstitial lung diseases commonly  complicates the management 
of connective tissue diseases (CTD). Hence a comprehensive 
understanding of the CTD and the usual course of Interstitial lung 
diseases (ILD) is important.    
 
                                Approximately 15% of the patients who present with ILD have an 
underlying CTD1. Furthermore clinical symptoms like cough, dyspnoea 
may be the first manifestation of rheumatologic diseases. Finally it can 
result in significant morbidity and mortality. 
 
                                The auto-immune mediated inflammation and fibrosis that 
characterizes these diseases can easily and irreversibly disrupt the normal 
functioning of the lung. As a group they can affect each portion of the lung: 
the pleura, alveoli, interstitium, vasculature, lymphatic tissue and of both 
small and large airways. 
 
                               The lung diseases associated with collagen vascular disorder may 
precede the clinical presentation of collagen vascular disease by 5 years 
or more1. 
 
                   
AUTOANTIBODIES ASSOCIATED WITH SPECIFIC COLLAGEN 
                               VASCULAR DISORDERS 
 
 
                 
DISEASES 
 
     ASSOCIATED   ANTIBODIES 
 
RHEUMATOID ARTHRTIS 
 
PROGRESSIVE SYSTEMIC 
SCLEROSIS 
 
 
MIXED CONNECTIVE TISSUE- 
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DERMATOMYOSITIS/ 
   POLYMYOSITIS 
 
SYSTEMIC LUPUS-     
- ERYTHEMATOSIS 
 
             SJOGRENS SYNDROME 
 
 
   RHEUMATOID FACTOR 
          
  ANTI-SCL -70 
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  ANTI RIBONUCLEAR PROTIEN 
 
  ANTI-JO-1 
 
  ANTI-ds-DNA 
  ANTI-sm 
 
 
  ANTI SS-A(Ro) 
  ANTI SS-B(La) 
 
                                             
                           
                                 Many of these diseases are characterized by the presence of the  
specific type of autoantibody which may greatly assist specific diagnosis. 
Most of the parenchymal manifestations of Collagen vascular diseases are 
similar to idiopathic interstitial pneumonia.  
 
           RHEUMATOID ARTHRITIS: 
                            It is a subacute or chronic inflammatory polyarthropathy of 
unknown cause that particularly affects peripheral joints.  Lung fibrosis 
associated with the  Rheumatoid arthritis (RA) was first reported by Ellman 
& Ball on 19482. Two most common histological pattern observed are UIP 
& NSIP.  
 
                                 Rheumatoid lung fibrosis is twice as common in men as in women 
with a mean age of onset of about 50 yrs. Rheumatoid arthritis is 
characterized by the presence of symmetric arthritis, morning stiffness, 
and rheumatoid factor in the blood. 
  
                                                 Pleuropulmonary complications are common and include interstitial 
pneumonitis and fibrosis, rheumatoid (necrobiotic) nodules, BOOP, 
bronchiectasis, obliterative bronchiolitis, follicular bronchiolitis, and pleural 
effusion or thickening 3,4. 
 
                                Interstitial pneumonitis and fibrosis are the most common 
pulmonary manifestations of rheumatoid arthritis3. In fact, pulmonary 
function abnormalities consistent with interstitial fibrosis have been 
reported in as many as 40% of patients who have rheumatoid arthritis4. In 
more than one-half of these patients, however, findings at chest 
radiography are normal. Evidence of interstitial fibrosis is seen at chest 
radiography in approximately 5% of patients with rheumatoid arthritis3,5  
and at high-resolution CT in 30%–40% 4,6. The complication is seen most 
frequently in men between 50 and 60 years of age 7.  
 
TYPES OF INTERSTITIAL PNEUMONIA: 
Nonspecific interstitial pneumonia (NSIP) 
Usual interstitial pneumonia (UIP) 
Cryptogenic organizing pneumonia (COP) 
Lymphocytic interstitial pneumonia (LIP). 
 
           The majority of patients who have interstitial fibrosis associated with 
rheumatoid arthritis have usual interstitial pneumonia; a small percentage 
have histologic findings of nonspecific interstitial pneumonia7. Nodular 
aggregates of lymphocytes may be prominent in both the parenchymal 
interstitium and in the interstitial tissue in bronchiolar walls and interlobular 
septa (follicular bronchiolitis) 8.  
 
                                In one report, a variety of histopathologic features were seen in 
specimens obtained at open lung biopsy in patients with rheumatoid lung 
disease8. Five different groups were identified on the basis of histologic 
patterns: pulmonary rheumatoid nodules, usual interstitial pneumonia, 
BOOP, lymphoid hyperplasia, and cellular interstitial infiltrates (nonspecific 
interstitial pneumonia). Few cases of diffuse alveolar damage have been 
reported 9.  
 
                   Radiologic Manifestations 
 
                                           In the early stage, the radiographic appearance 
consists of irregular linear hyperattenuating areas in a fine reticular pattern. 
The abnormality usually involves mainly the lower lung zones. With the 
progression of disease, the reticular pattern becomes more coarse and 
diffuse, and honeycombing may be seen 10.  
 
                                 Similar to the findings at radiography, the predominant abnormality 
at high-resolution CT consists of irregular linear hyperattenuating areas 
caused by a combination of intralobular lines and irregular thickening of 
interlobular septa4. Honeycombing is seen, most markedly near the 
diaphragm. 
  
                                In a study by Akira et al11, three predominant CT patterns were 
identified in 29 patients: reticulation with or without honeycombing (n = 
19), centrilobular branching linear structures with or without bronchial 
dilatation (n = 5), and consolidation (n = 5). Reticulation and centrilobular  
                       branching linear structures corresponded to the histopathologic findings of 
usual interstitial pneumonia and BOOP, respectively. Consolidation 
corresponded to BOOP with or without findings of coexistent chronic 
eosinophilic pneumonia. Reticulation deteriorates rapidly, especially when 
it is associated with the new appearance of multifocal areas of ground-
glass attenuation.  
 
                                                 Centrilobular branching linear structures show a tendency to 
progress to bronchiectasis. Consolidation shows a tendency to improve in 
one-half of patients and to evolve into honeycombing in the remaining 
patients at serial CT.  
 
                                Interstitial lung changes are frequent and independent of disease 
duration. Interstitial changes are more frequent and severe in rheumatoid 
factor–positive patients and in patients with more severe joint 
involvement12.   
 
 
 
 
 
 
  
PROGRESSIVE SYSTEMIC SCLEROSIS: 
 
It is a generalized connective tissue disorder characterized by; 
Tightening, induration & thickening of the skin (SCLERODERMA) 
Raynauds phenomenon & other vascular anomalies. 
Musculo-skeletal manifestations. 
Visceral involvement particularly GIT, lungs, heart and kidneys 
                             
 The lung is the fourth most commonly affected structure after skin, 
vessel and esophageal involvement2. The diagnosis can be made with 
high degree of certainity if the single major criterion of proximal 
scleroderma is present or if there are 2 or more minor criteria 
(sclerodactyly, pitting scars or loss of the substance of the finger tips or 
bilateral basal pulmonary fibrosis) 2. 
                                 PSS has 3:1 female to male distribution and presents more 
commonly in the 3rd -5th decade of life. Clinical syndrome of scleroderma 
may rarely occur in relationship with silicosis (ERASMUS SYNDROME). 
 High resolution computerized tomography  findings in PSS have been      
described: 
Ground glass opacification. 
Fine reticular pattern (posterior and sub pleural). 
Honey combing with sub pleural cysts. 
Lines of various types (septal, sub pleural, long ) 
Sub pleural micronodules. 
 
           Lung fibrosis associated with the scleroderma holds much better 
prognosis than that found in IPF2. This is most likely due in part to the 
predominant NSIP histology. Progressive systemic sclerosis 
(scleroderma), an uncommon disease with an estimated incidence of 
approximately 10 cases per million per year, is a disorder of connective 
tissue characterized by deposition of excessive extracellular matrix and 
vascular obliteration 13.  
 
Diffuse and limited forms of systemic sclerosis refer to the extent of 
cutaneous involvement, with a different clinical course and prognosis for 
each. Both types are more common in women, although the diffuse form 
tends to involve older women.  
 
Pulmonary involvement is more common and more severe in 
systemic sclerosis than in other types of collagen vascular disease. The 
most common pulmonary manifestation is interstitial fibrosis, which occurs 
in approximately 80% of patients13. Pulmonary fibrosis is equally likely in 
the limited and diffuse forms of the disease but is less severe in the limited 
form.  
Histopathologic Characteristics 
           At autopsy, some degree of parenchymal interstitial fibrosis is 
frequently seen. The histologic features are those of nonspecific or usual 
interstitial pneumonia, the former being more common. Follicular 
bronchiolitis is seen occasionally. Although BOOP may be associated with 
scleroderma, obliterative bronchiolitis is only rarely seen with the 
disease14. Diffuse alveolar damage has rarely been recognized in 
association with scleroderma15. 
 
Radiologic Manifestations 
 Evidence of interstitial fibrosis has been reported at chest 
radiography in 20%–65% of patients13. Serial radiographs obtained over 
several years may show progressive loss of lung volume in addition to a 
worsening of the interstitial disease.  
 
           High-resolution CT frequently shows evidence of interstitial 
pneumonitis and fibrosis in patients who have normal or questionable 
radiographic findings16,17 . The abnormalities involve mainly the lower 
lobes and have a predominantly peripheral and posterior distribution18. 
 
                                In a recent study by Kim et al19, findings at serial high-resolution CT 
were correlated with the results of pulmonary function tests in 40 patients 
with progressive systemic sclerosis and interstitial pneumonia. The overall 
extent of disease and the degrees of honeycombing and ground-glass 
attenuation increased significantly at follow-up CT. 
 
                                 Both forced vital capacity and forced expiratory volume in 1 second 
decreased significantly at follow-up. The increase in the extent of 
honeycombing at CT correlated significantly with the decrease in diffusing 
capacity for carbon monoxide. The average rate of progression of 
honeycombing in patients with idiopathic usual interstitial pneumonia is 
0.4% of lung volume per month20. According to study by Kim et al19the 
progression rate of honeycombing in patients with progressive systemic 
sclerosis is 0.07% of lung volume per month.  
 
 
 
 
 
 
 
 
 
 
 
 
           SYSTEMIC LUPUS ERYTHEMATOSUS 
 
                                 It is a multisystem collagen vascular disorder that particularly 
affects vessel, serosa, joints, kidneys, CNS, skin and blood vessels. The 
overall prevalence rate of SLE is about 20-50 cases per 105 population 
and it is 10 times as common in women as in men, with an increased 
prevalence among relatives and blacks2. The illness characteristically 
shows relapses and remissions and it presents typically in women of 
childbearing age with a wide variety of manifestations, particularly those of 
joint, skin (malar rash, photosensitivity, livedo reticularis), and systemic 
disorders.  
 
                                Thoracic involvement is common in SLE, and the lungs, pleura, 
heart, diaphragm, and intercostals muscles may all be affected. Thoracic 
manifestations can be divided into primary changes or secondary 
complications. 
 
                                 Pulmonary manifestations of systemic lupus erythematosus 
comprise both acute and chronic lesions. Acute disease includes 
pulmonary hemorrhage, acute lupus pneumonitis, and pulmonary edema. 
Chronic disease, such as interstitial pneumonitis and fibrosis, is less 
common than in other connective tissue disorders 21. 
 SUBACUTE OR CHRONIC INTERSTITIAL PNEUMONIA 
Nonspecific interstitial pneumonia. 
Organizing pneumonia. 
Usual interstitial pneumonia. 
 
           ACUTE LUPUS PNEUMONITIS 
                                 Acute lupus pneumonitis is characterized histologically by changes 
of diffuse alveolar damage (DAD). This is an unusual life-threatening 
condition characterized by acute onset of fever, cough, tachypnea, 
hypoxia, and radiologic consolidation and is a diagnosis of exclusion. It 
occurs in 1%–4% of patients22,23. Histopathologic findings include alveolar 
wall damage and necrosis that lead to inflammatory cell infiltration, 
hemorrhage, edema, and hyaline membrane formation .Large vessel 
vasculitis has rarely been detected. Thrombi in small vessels, associated 
with an interstitial pneumonitis, have been well documented, although this 
finding is an unusual feature of acute lupus pneumonitis. The 
pathogenesis of these histologic changes remains controversial 21. 
 
            PULMONARY FIBROSIS 
                                Fibrotic interstitial lung disease is generally regarded as an unusual 
manifestation of SLE. A numerous patients with lung fibrosis have had 
preceding acute pneumonitis and the interstitial changes presumably 
represent the organizing phase of DAD. Interlobular and intralobular lines 
were the most common type of abnormality. The most common signs 
were thickened interlobar septa, parenchymal bands, subpleural bands, 
and pleural tags and thickening. 
 
Systemic lupus erythematosus is characterized immunologically by 
the presence of autoantibodies against various nuclear antigens. 
Pleuropulmonary involvement occurs in approximately 50%–60% of 
patients. Most such involvement consists of pleural disease23. In one 
prospective study that included 1,000 patients, lung involvement was 
identified in only 3% at the onset of the disease; it developed in an 
additional 7% over the period of observation24.  
 Radiologic  Manifestations 
            Ground-glass attenuation and consolidation at high-resolution CT 
may reflect the presence of interstitial pneumonitis and fibrosis, acute 
lupus pneumonitis, hemorrhage, or, occasionally, BOOP.  Radiographic 
evidence of interstitial fibrosis, consisting of a reticular pattern that involves 
mainly the lower lung zones, is seen in only about 3% of patients who 
have systemic lupus erythematosus. 
 
By contrast, interstitial abnormalities are seen in approximately 30% 
of patients at high-resolution CT25,26. They include interlobular septal 
thickening (33%), irregular linear hyperattenuating areas (33%), and 
architectural distortion (22%). Such abnormalities are usually mild and 
focal; diffuse disease seen in only 4% of patients22. Honeycombing is 
uncommon.  
 
POLYMYOSITIS / DERMATOMYOSITIS 
                                They are diffuse inflammatory myopathies of striated muscle. 
Polymyositis is an autoimmune inflammatory myopathy characterized by 
symmetric weakness of the limb girdle and anterior neck muscles27.  
Additionally, in dermatomyositis there are characteristic skin changes. 
Female patients outnumber males by about 2:1. Polymyositis and 
dermatomyositis have an incidence of approximately 5–10 cases per 
million per year27. 
 
DIAGNOSTIC CRITERIA FOR POLYMYOSITIS AND  DERMATOMYOSITIS 
Proximal muscle weakness (Symmetric, present for weeks or  
months). 
Muscle biopsy showing necrobiotic and inflammatory changes. 
Raised muscle enzymes (Creatine phospohokinase). 
Characteristic electromyography. 
Characteristic skin rash. 
           In dermatomyositis, additional characteristic skin changes are 
present: Heliotrope periorbital rash and Violaceous / red papular rash  
 
  
over bony prominences. Pulmonary involvement is quite common in 
polymyositis / dermatomyositis and may occur in up to 50% of patients. 
          The thorax is commonly affected, generally in one or more of three 
forms: (a) hypoventilation and respiratory failure as a result of involvement 
of the respiratory muscles; (b) interstitial pneumonitis, usually with a 
histologic pattern of usual interstitial pneumonia or nonspecific interstitial 
pneumonia; and (c) aspiration pneumonia secondary to pharyngeal 
muscle weakness (probably the most common pulmonary complication) 
27,28.  
 
 INTERSTITIAL LUNG DISEASE  
                                Interstitial fibrosis was first described in dermatomyositis in 1956 by 
Mills and Matthews. It is now a well recognized association that occurs in 
5-10% of patients2. The presence of interstitial lung disease (ILD) in 
polymyositis / dermatomyositis correlates strongly with the presence of 
anti-Jo-1, a myositis specific autoantibody directed against a cellular 
enzymes (histidyl-t-RNA synthetase). 
   
                                It is said that the ILD of polymyositis/ 
dermatomyositis is more steroid responsive than that of systemic 
sclerosis, perhaps due to a higher prevalence of OP2. 
                                  
                                             
                                 Pathologic findings include: NSIP, OP, UIP (the frequency is less 
than in other collagen vascular disorders); DAD  (which in the organizing 
phase is probably equivalent to AIP) vasculitis (small/medium vessel), 
primary pulmonary arterial fibroproliferative changes, diffuse pulmonary 
hemorrhage with capillaritis, and chronic eosinophilic pneumonia. More 
recent experience indicates that NSIP is more common than OP though a 
mixture of the two is frequent. 
 
                                 Radiographic changes commonly consist of symmetric basally 
predominant, reticulonodular opacity. The more acute cases may show 
areas of airspace opacity. In time, pulmonary changes can progress to 
involve the whole lung, and a fine honeycomb pattern. 
 
                                 The imaging findings depend on the type of histologic abnormality. 
In patients with histologic NSIP, ground-glass abnormality and reticular 
abnormality with traction bronchiectasis are the most common features, 
though consolidation may also occur. Pathologic correlation showed that 
patchy consolidation and ground-glass opacity was produced by OP, 
whereas extensive consolidation and ground-glass opacity indicated DAD. 
Honeycomb opacity is equated with UIP. 
  
  Histologic appearance is useful for determining the prognosis28. 
Patients with diffuse alveolar damage or usual interstitial pneumonia have 
a poor prognosis, with only a 33% survival rate at 5 years29. However, 
patients with BOOP have an excellent prognosis. Patients with nonspecific 
interstitial pneumonia have a good prognosis.  
 Radiologic Manifestations            
  The frequency of radiographic parenchymal abnormalities is low 
(about 5%). The most common is a symmetric, predominantly basal 
reticular pattern that may become diffuse over time and progress to 
honeycombing 27.        
                                 Bilateral areas of consolidation develop in some patients over a 2-3 
week period. This abnormality usually corresponds histologically to diffuse 
alveolar damage or BOOP28.  Initial high-resolution CT findings of 
pulmonary involvement in patients with polymyositis or dermatomyositis 
are prominent interlobular septa, ground-glass attenuation, patchy 
consolidation, parenchymal bands, irregular peribronchovascular 
thickening, and subpleural lines.  
 
                                 Honeycombing may be seen in up to 16% of patients who have 
abnormal chest radiographic findings or pulmonary function30. Areas of 
consolidation with or without ground-glass attenuation correspond 
histopathologically to BOOP or organizing diffuse alveolar damage. Patchy 
consolidation, parenchymal bands, and irregular peribronchovascular 
thickening are seen to improve at sequential CT, becoming pleural 
irregularities, prominent interlobular septa, ground-glass attenuation, and 
subpleural lines on follow-up CT scans 31,32. Therefore, consolidation with 
patchy and subpleural distribution, parenchymal bands, and irregular 
peribronchovascular thickening are reversible. On occasion, areas of 
ground-glass attenuation with parenchymal bands or subpleural lines that 
represent a pathologic area of usual interstitial pneumonia may progress 
to honeycombing 31. 
 
          SJOGREN SYNDROME 
                                 Sjogren syndrome (Sicca syndrome) is an autoimmune disorder 
characterized by clinical triad of dry eyes (keratoconjunctivitis sicca),dry 
mouth (xerostomia) and arthritis that particularly affects middle-aged 
females.  
 
                                 Pathologically, the hallmark of sjogren syndrome is widespread 
tissue infiltration by polyclonal B lymphocytes. It is relatively common, 
affecting 0.1% of the general population and 3% of older adults 33.It may 
be primary, without features of other collagen vascular disease, or 
secondary in association with other collagen vascular disease, most often 
rheumatoid arthritis. 
 
 
 EUROPEAN CLASSIFICATION CRITERIA FOR SJOGREN SYNDROME 
(FOUR OR MORE POSITIVE CRITERIA INDICATE PRIMARY 
SJOGREN SYNDROME) 2. 
 
Dry eyes. 
Dry mouth. 
Signs of keratoconjunctivitis sicca (Schirmer test and/or rose     
Bengal test positive). 
Minor salivary gland histopathology- positive for focal mononuclear 
cell agglomerations. 
Objective salivary gland involvement (one or more tests positive). 
Salivary scintigraphy. 
Parotid sialography. 
Unstimulated salivary flow. 
Antoantibodies (antibodies to Ro[SS-A] and / or La[SS-B]). 
 
                                The pleuro-pulmonary manifestations of sjogrens syndrome  
reviewed  by Caine et al falls in to 3 main groups. 
Airway dryness, hoarseness & obstruction. 
Lymphoproliferative 
Manifestations of collagen vascular disorders. 
 
  
                                 The most common thoracic complication, lymphocytic interstitial 
pneumonia, is followed in frequency by airway abnormalities such as 
follicular bronchitis, bronchiectasis, and bronchiolitis. Less common 
complications include interstitial pneumonitis and fibrosis, BOOP, 
lymphoma, pulmonary hypertension, and pleural effusion or fibrosis 33  . 
 
In the chest imaging, most of the common pulmonary 
manifestations particularly NSIP, UIP & LIP give rise to basal predominant 
nodular or reticulo-nodular shadows. 
 
Radiologic Manifestations 
           Parenchymal abnormalities are evident at chest radiography in 
10%–30% of patients34. The most common finding, a reticulonodular 
pattern that involves mainly the lower lung zones, may reflect the presence 
of lymphocytic interstitial pneumonia or interstitial fibrosis.  
Franquet et al 35 made a prospective study of high-resolution CT 
findings in the lungs of 50 consecutive patients in whom the onset of 
disease occurred an average of 12 years prior to CT (range, 2–37 years). 
Moreover, 37 of 50 patients (74%) had no respiratory symptoms at the 
time of CT.  
 
                                The authors detected abnormalities in 17 patients (34%) at CT and 
in only seven patients (14%) at chest radiography. The most common 
findings were bronchiolectasis and poorly defined centrilobular nodular or 
branching linear hyperattenuating areas (seen in 11 patients), (areas of 
ground-glass attenuation (seven patients), and honeycombing (four 
patients). Honeycombing alone or both honeycombing and ground-glass 
attenuation suggestive of pulmonary fibrosis were bilateral, asymmetric, 
and present almost exclusively in the periphery of the lower lobes.  
 
OVERLAP SYNDROME AND MIXED CONNECTIVE TISSUE 
DISORDER 
 
                                Some patients have an illness with the characteristic features of 
more than one connective tissue disorder; such patients are said to have 
an overlap syndrome or undifferentiated connective tissue disorder. 
                                 Mixed connective tissue disease (MCTD) is an overlap syndrome 
that is a distinct clinicopathologic entity. The principal characteristics are 
the presence of (1) features of SLE, systemic sclerosis, polymyositis / 
dermatomyositis, occurring together or evolving sequentially during 
observation and (2) Antibodies to an extractable nuclear antigen (RNP).  
Respiratory involvement has been described in 20%–80% of patients. 
Common pulmonary abnormalities include interstitial pneumonitis and 
fibrosis, pulmonary hypertension, and pleural effusion36. 
 
                                Suggested clinical criteria for the diagnosis are (1) positive anti-
RNP plus (2) Three or more clinical features – hand edema, synovitis, 
myositis, Raynaud phenomenon, acrosclerosis. After several years MCTD 
may transform into one of the classic collagen vascular diseases.  
 
           Histopathologic findings of pulmonary involvement in mixed 
connective tissue disease are classified into interstitial fibrosis and 
vascular changes. Interstitial fibrosis has the appearance of usual or 
nonspecific interstitial pneumonia. Typical vascular changes consist of 
bland intimal proliferation of the lung arterioles, plexogenic angiopathy, 
and chronic pulmonary emboli 36. 
 
                                 In a review of the CT findings in 41 patients with MCTD, Kozuka et 
al found ground glass attenuation in all patients. Sub pleural 
micronodules, non septal linear and reticular abnormalities were all found 
in more than 50% of cases with CT pattern corresponding closely to NSIP.  
 
           The frequency of pulmonary abnormalities varies considerably in 
different series. For example, in a retrospective study of 81 patients at the 
Mayo Clinic 37, an interstitial pattern was seen at chest radiography in 
19%; on the other hand, careful prospective study of 34 patients in another 
investigation38, showed interstitial abnormalities in 85%. The abnormalities 
consist of irregular linear hyperattenuating areas with a reticular pattern 
and involving mainly the lung bases. With the progression of disease, the 
fibrosis gradually extends superiorly; in the late stage, honeycombing may 
be identified. High-resolution CT shows a predominant subpleural 
distribution of fibrosis. Other radiologic abnormalities include areas of 
parenchymal consolidation that may be related to BOOP 39. 
  
 Radiologic Manifestations 
             The frequency of pulmonary abnormalities varies considerably in 
different series. For example, in a retrospective study of 81 patients at the 
Mayo Clinic37, an interstitial pattern was seen at chest radiography in 19%; 
on the other hand, careful prospective study of 34 patients in another 
investigation38, showed interstitial abnormalities in 85%.  
 
                                The abnormalities consist of irregular linear hyperattenuating areas 
with a reticular pattern and involving mainly the lung bases. With the 
progression of disease, the fibrosis gradually extends superiorly; in the late 
stage, honeycombing may be identified. High-resolution CT shows a 
predominant subpleural distribution of fibrosis. Other radiologic 
abnormalities include areas of parenchymal consolidation that may be 
related to BOOP39. 
 
 
        
HIGH RESOLUTION COMPUTERISED TOMOGRAPHY FINDING IN ILD40 
 
 
  DIP &RB-ILD 
  
                        SMOKING RELATED GROUND GLASS OPACITY  
& CENTRILOBULAR NODULES 
 
  LIP 
 
GROUND GLASS OPACITY & PERIVASCULAR CYST 
 
           NSIP 
 
BASAL GROUND GLASS & / RETICULAR PATTERN 
& TRACTION BRONCHIECTASIS 
 
          IPF(UIP)   
 
BASAL & PERIPHERAL RETICULAR PATTERN + 
HONEY COMBING & TRACTION BRONCHIECTASIS 
 
            AIIP 
 
DIFFUSE LUNG CONSOLIDATION & GROUND 
GLASS   OPACITY 
 
                  
 
           SPIROMETRY: 
                                 Spirometry is the measure of airflow during inspiration and 
expiration. It can be easily performed in the physician consulting room, 
with simple and affordable equipments called spirometer. The test is 
performed in sitting posture (by convention) and airflow is recorded as 
forced and sustained expiration followed by forced and sustained 
inspiration. 3 efforts, which have less than 5% and 100ml variability 
between each other, are selected and best effort is used for interpretation. 
  
                                Routinely, only expiratory flow may be recorded before and after 
administration of bronchodilators. However  both inspiratory and expiratory 
are required for evaluation of upper airway obstruction. 
 
           SPIROMETRY IS USEFUL FOR THE FOLLOWING: 
• Evaluation of cases with respiratory symptoms. 
• Assessment of severity of respiratory disorders. 
• Assessment of response to therapy. 
• Pre operative pulmonary evaluation. 
• Detection of pulmonary abnormalities in predisposed     
individuals (e:g) occupational exposure, neuromuscular, 
chest wall or upper respiratory disorders. 
 
SPIROMETRIC EQUIPMENT: 
           American Thoracic society (ATS) recommends that the equipment 
should be such that it meets the minimum standards i.e. 
• Should record 7 litres volume and 12L/sec flow rate. 
• Should be calibrated with a 3L syringe. 
• Should record minimum FVC and FEV1  and  
• Should record flow volume curve or flow volume loop or both. 
 
                                  
Subclinical interstitial lung involvement in rheumatic diseases was 
studied by Salaffi F and co workers. They correlated high resolution 
computerized tomography with functional and cytologic findings. Results 
of that Italian study is summarized below. 
 
 (41.2%) had abnormal High resolution computerized tomography 
findings. Chest X-ray showed parenchymal abnormalities in only 15 
patients (18.7%) who had evidence of fibrosis on High resolution 
computerized tomography. Abnormal differential cell counts (alveolitis) at 
bronchoalveolar lavage were found in (57.5%). Three types of alveolitis 
were observed: pure lymphocyte alveolitis, pure neutrophil alveolitis, and 
neutrophil alveolitis associated with lymphocytosis (mixed alveolitis).  
 
The patients with neutrophil alveolitis had more extensive disease 
on High resolution computerized tomography than those with lymphocyte 
alveolitis or with normal cellular patterns at bronchoalveolar lavage. The 
extent of a reticular pattern on High resolution computerized tomography 
correlated with the neutrophil rate (p = 0.001) and total count (p = 0.003) 
on bronchoalveolar lavage. Eosinophil and lymphocyte rate and total 
count correlated (p < 0.05) with the extent of the ground-glass pattern on 
High resolution computerized tomography. Lung volumes were not 
significantly different among patients with ground-glass pattern and those 
with reticular patterns on High resolution computerized tomography.  
   J. Biederer  correlated  High resolution computerized tomography 
findings, pulmonary function tests and bronchoalveolar lavage cytology in 
interstitial lung disease associated with rheumatoid arthritis and was 
published on line on 14 October2003. He found out that the High 
resolution computerized tomography appears most appropriate for the 
detection and follow-up of ILD associated with RA. The pulmonary 
function test and Bronchoalveolar lavage correlate only partially with 
lesion profusion or grading on High resolution computerized tomography, 
but they contribute valuable information about dynamic lung function. 
 
Most of the DPLDs disclose a restrictive ventilatory pattern and low 
lung volumes in the pulmonary function tests (PFTs). However, some 
DPLDs may show obstructive patterns due to the bronchocentric nature of 
involvement; examples are sarcoidosis, chronic HSP, some presentations 
of rheumatoid arthritis, LAM, silicosis, allergic bronchopulmonary 
aspergillosis. 
  
           HIGH RESOLUTION COMPUTERISED TOMOGRAM: 
                   In diffuse lung disease, it is generally accepted that the advent of 
high-resolution computed tomography (HRCT) has been the major 
diagnostic advance of the last 2 decades. High resolution computerized 
tomography is now an integral part of routine diagnostic evaluation, and its 
use has had a major impact on the utility of other diagnostic tests, 
especially bronchoalveolar lavage and surgical biopsy procedures. 
However, as with all new diagnostic tests, the routine diagnostic 
application of High resolution computerized tomography has evolved 
slowly. The landmark diagnostic High resolution computerized tomography 
series were performed in the late 1980s and early 1990s but their 
extrapolation to clinical practice was largely confined to referral centers 
during that period41. 
 
           The advantages and limitations of High resolution computerized 
tomography continued to be defined in subsequent series with a recent 
emphasis on the idiopathic interstitial pneumonias but histologic 
evaluation remained, for most clinicians, the diagnostic "gold standard" 
throughout the 1990s41. This view is increasingly questioned and it is now 
accepted that, in some contexts, High resolution computerized 
tomography evaluation obviates biopsy procedures. 
 
 This conclusion had recently been reinforced by the formulation of 
noninvasive diagnostic criteria for idiopathic pulmonary fibrosis (IPF). 
However, histologic assessment remains pivotal in other instances, and 
thus it is timely to explore the difficulties still faced by clinicians and 
radiologists in applying the diagnostic High resolution computerized 
tomography series to routine practice. The prevailing issue, pertaining to 
referral and non referral populations alike, is the problem of extrapolating 
academic diagnostic series, containing large cohorts of patients with 
diffuse lung diseases, to individual patients. 
  
   Flexible bronchoscopy (FBS)                     
Flexible bronchoscopy (FBS) is an universally well accepted 
procedure both in the diagnosis and therapy of various pulmonary 
disorders. An experienced pulmonologist can perform this elegant 
procedure safely, follow the necessary precautions and increase the 
diagnostic yield in obscure respiratory diseases. 
 The birth of the bronchoscope was as early as 1897 when German 
laryngologist- Gustav Killian, "father of bronchoscopy" used a metal rod to 
remove an aspirated pork bone from a man's right main bronchus. Later in 
Philadelphia, Chevalier Jackson in 1904 modified the rigid bronchoscope 
(RB) with the addition of a direct ocular mechanism, suction tube and 
distal illumination.  
The discovery of fiberoptics, that threads of glass could transmit 
light from one end to the other, can be traced back to 1870, but it was not 
until 1964 that this technology finally led Shigeto Ikeda of the National 
Cancer Institute, Tokyo, to develop the flexible fiberoptic bronchoscope.  
 RB until then was used to examine airways. Today there are two 
major types of bronchoscopes i.e. the rigid Jackson bronchoscope and the 
flexible fiberoptic bronchoscope (FBS). The flexible bronchoscope has 
continued to gain utility primarily as a diagnostic tool. However, recently it 
has also become a popular modality for many therapeutic purposes. 
            BRONCHO ALVEOLAR LAVAGE: 
      It is the lavage of the bronchoalveolar secretions from the lower 
respiratory tract and is an important procedure that can be performed 
during bronchoscopy. This technique helps in the recovery of both cellular 
and non-cellular components from the epithelial surface of the lower 
respiratory tract and it differs from bronchial washings, which is usually an 
aspiration of secretions from the large airways. Hence Bronchoalveolar 
lavage can be called the 'liquid biopsy of the lung.  
 
                                 For Bronchoalveolar lavage the scope is wedged into the desired 
subsegmental bronchus of localised lung lesions or to the right middle 
lobe, in diffuse lung disease. 2-5 ml/kg of sterile, prewarmed normal saline 
in 3 equal aliquots are instilled through the port of the scope and 
subsequently aspirated back into specimen trap using suction. The 
specimens are labeled and transported to the laboratory immediately or 
within one hour in an ice container for bacteriological, cytological and 
immunological evaluation.  
 
The  normal cellular content of the Bronchoalveolar lavage fluid is 
 80%   alveolar macrophages  
10%     lymphocytes  
 1-3%    polymorphonuclear cells  
1%       eosinophil.  
 
                                The ratio of CD4 T helper and CD8 T suppressor/ cytotoxic cells is 
about 1:5. In tuberculosis, sarcoidosis and hypersensitivity pneumonitis, 
Bronchoalveolar lavage shows lymphocytosis and there is neutrophilic 
predominance in interstitial pulmonary fibrosis.  
   
                                  In patients with AIDS and other immunodeficiency diseases 
Bronchoalveolar lavage is helpful in diagnosing opportunistic infections 
like pneumocystis carini, cytomegalovirus, aspergillus fumigatus, candida 
albicans, legionella pneumophilia and other pathogens. Bronchoalveolar 
lavage also plays an important role in the therapeutic management of 
alveolar proteinosis. Thus a high yield of meaningful clinically information 
can be expected from FBS when coupled with Bronchoalveolar lavage. 
 
 
 
 
 
 
 
 MATERIALS AND METHODS 
 
                                The study was organized in the Institute of Thoracic Medicine 
(I.T.M) and Department of Thoracic Medicine in association with 
Rheumatology  Department , Madras Medical College.  
    
                                 The design of the work is a prospective case study. It extends from 
the period of January 2005 to November 2005 and it is performed at the 
Department of Thoracic Medicine with source population from the 
Department of Rheumatology-Madras Medical College-Chennai. 
 
 INCLUSION CRITERIA 
1). Serologically positive collagen vascular disorder patients.  
2). Clinically and radiologically confirmed cases of Interstitial 
 Lung  Diseases (ILD). 
 
 EXCLUSION CRITERIA  
1). Patient associated with co-morbid illness like congestive 
 cardiac failure, tuberculosis and malignancy.  
2). Smokers are virtually eliminated from the study since it is a 
confounding factor for (e:g) the respiratory bronchiolitis of 
smoking can be falsely attributed to collagen vascular 
disorders.  
3). ILD’s due to other etiologies. 
 Granulamatous diseases 
 Environmental & occupational 
 Iatrogenic & drug induced 
 Idiopathic interstitial pneumonia 
 Unique entities 
 Inherited                                                                                
                     4)  ILD mimickers.  
 
                        In essence without a medical history, all ILDs are of 
unknown cause. For an accurate diagnosis there is no substitute for 
complete clinical evaluation. This should be considered the key diagnostic 
step in the evaluation of patient who has ILD. 
 
                                This includes a thorough history elicitation, with comprehensive 
evaluation of the chief complaint; a comprehensive review of multiple 
systems; identifications of all medications and drugs, including over the 
counter and naturopathic medications. 
 
 
 
Then followed by exhaustive review of past medical, social, family 
and occupational histories with an exploration of all potential  
environmental exposures is done. The clues that surface during this 
evaluation helps to narrow the broad differential diagnosis to few possible 
disorders. 
 
           PULMONARY FUNCTION TEST (PFT): 
After completing the physical examination of those who have full 
filled the criteria, were subjected to PFT. Before doing the PFT the various 
maneuvers of PFT were explained and practically demonstrated to them. 
PFT was deferred to those persons who were suspected of having 
respiratory tract infection. A course of antibiotic was given for them and 
asked to come for the next session for the completion of PFT. 
               
`  PFT was done using MIR spirolab in which evaluation and 
interpretation of the values were made by comparing with specific 
predicted or normal values taken from a healthy population. 
 
 For all personnel FVC and FEV1/FVC were recorded and recorded  
values are taken as print out. One copy of the spirometry report was given 
to the person concerned for their reference. 
 
AMERICAN THORACIC SOCIETY (ATS) RECOMMENDATIONS FOR 
PERFORMING THE SPIROMETRY42 
 
Effort                           :    Maximal, smooth and cough free. 
Position                       :    Sitting. 
Exhalation time           :    6 seconds. 
End of test                   :   2 seconds volume plateau. 
Reproducibility             :   FVC with in 5% in 3 acceptable tests. 
 
 
           HIGH RESOLUTION COMPUTERISED TOMOGRAPHY (HRCT)    
                    
 The patients were then subjected to the High Resolution 
Computerized Tomogram (HRCT). The High resolution computerized 
tomography evaluation is done which includes characterization of pattern 
and profusion of the lesion on representative anatomical levels. High-
resolution computed tomography (HRCT) has a central role in the routine 
detection and diagnosis of individual diffuse lung diseases.  
 
 
 
 
 
            BRONCHO ALVEOLAR LAVAGE (BAL): 
 It is also known as liquid biopsy or window of the lung. After a 
thorough history, clinical examination and pulmonary function tests,  
patients were subjected to Bronchoalveolar lavage. 
 
 Lung parenchymal evaluation by High resolution computerized 
tomography scanning of the chest has evolved to the point that it may 
provide images that are virtually diagnostic of certain forms of ILD but 
other tests like Bronchoalveolar lavage is required to secure an accurate 
diagnosis. 
                         
Bronchoalveolar lavage provides a safe and generally well tolerated 
means of retrieving secretions that coat the surface of bronchial and 
alveolar epithelium. Certain patterns of differential cell count correlate well 
with certain forms of ILD. 
 
            PROCEDURE: 
The most important objective is to have adequate amounts of 
instilled saline reach the pathological sites that are involved by the disease 
so that the retrieved Bronchoalveolar lavage fluid reflects changes in cells 
and solutes caused by the inflammatory process. 
 
  
100-200 ml of 0.9% prewarmed and buffered isotonic saline is 
instilled and 20mI aliquots are frequently employed. Middle / lingular lobe 
is the preferred site. Typically these sites are easily entered with the 
bronchoscope and the distal end of it can be wedged safely in segmental 
bronchi. Positioning the patient in such a way that the areas to be lavaged 
are not in the gravity dependent thereby it facilitates better retrieval of 
Bronchoalveolar lavage fluid. 
 
Keeping the amount of negative pressure to a minimal level that 
allows retrieval of fluid prevents airway collapse unless advanced 
emphysema is present. Wall suction is applied with caution to generate 
negative suction pressure and kept at low value (25-100mm Hg). 50-80% 
of the  instilled fluid is recovered. 
           
Further samples are collected in a siliconised plastic container. 
Bronchoalveolar lavage fluid sample is immediately transported, filtered 
and centrifuged for 10 min at 500g. Counts are enumerated using cell 
smear technique and staining is done with Giemsa stain. 
 
 
 
 May - Grunwald (Giemsa) Staining Procedure 
Purpose:              
This standard operating procedure (SOP) establishes the standard 
for staining bacteria or mast cells using the May-Grunwald (Giemsa) 
staining procedure. 
Reagents and Materials: 
               Jenner  Solution 
                Giemsa Solution                    
                Store at room temperature. 
                    1% Acetic Acid 
                     Acetic Acid                       5ml 
                     Distilled water              495ml 
Materials 
                          Specimen slides and control slides for special stain requested. 
                Microwave to bake slides. 
                Staining rack  
                Coverslips  
Calibration and Standardization: 
 Procedure: 
Deparaffinize and hydrate with distilled water. 
Add Methanol for 6 minutes. 
           Then to add Jenner Solution (working) for  6 minutes. 
         Make fresh:    Jenner Stain          20ml 
                                 Distilled water        20 ml 
 
                      Then to add Giemsa  Solution  (working) for 45 minutes. 
         Make fresh:     Giemsa Stain          1ml 
                                  Distilled water         50ml 
 
    Then to be rinsed with Distilled water , followed by 
     4 dips in 1% AceticAcid and to be rinsed with Distilled water   
     Dehydrate and clear it and  then to apply coverslip.  
          Results: 
              Nuclei  -  blue 
                Cytoplasm  -  pink to rose 
                Bacteria or Mast Cells – blue   
Statistical Analysis  
           Following statistical analysis are done to assess the strength of 
association between the variables of the study. They are 
Student t-test 
Chi-square test 
Diagnostic statistics 
               Sensitivity 
                Specificity 
                Correct classification 
Agreement statistics 
Kappa statistics 
McNemar’s test 
 RESULTS 
 
                         In our study 60 patients were screened for interstitial lung 
diseases. Out of which 55 patients were taken up for the study after 
satisfying the eligible criteria. Remaining 5 patients were excluded from 
the study group based on the exclusion criteria.   
AGE: 
           In our study population, age ranges from 19yrs – 54 yrs (Fig 1). 
 
AGE IN YEARS 
 
NO. OF PATIENTS 
 
PERCENTAGE 
 
15-24 
 
3 
 
5.5 
 
25-34 
 
18 
 
32.7 
 
35-44 
 
22 
 
40 
 
45-55 
 
12 
 
21.8 
 
TOTAL 
 
55 
 
100 
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  Fig 1.    Age distribution. 
 
 
 
 
 
SEX DISTRIBUTION
44%
56%
male female
 
  Fig 2.    Sex distribution. 
 
 Maximum number of patients presented between the age of 25--44 
years. Mean age distribution found in our study is 37. The calculated 
standard deviation is 7.98. Hence 95% of confidence interval lies in the 
age range of  (37±15.96), indicating that the most of them falls in the late 
fourth decade. 
 
          SEX: 
                     No. of males                                              :    24 
                     No. of females                                           :    31 
                     Male and female sex ratio (Fig 2)              :    1:1.3 
.   
SEX INCIDENCE OF DPLD IN RELATION TO COLLAGEN VASCULAR 
DISORDER 
 
FEMALE MALE  
                       TYPES NO PERCENTAGE NO PERCENTAGE 
                RHEUMATOIDARTHRITIS 13 42 6 26 
                SYSTEMIC SCLEROSIS 8 26 12 50 
SYSTEMIC LUPUS ERYTHEMATOSUS 4 13 1 4 
  POLYMYOSITIS/DERMATOMYOSITIS 3 10 1 4 
SJOGRENS SYNDROME 2 6 2 8 
OVERLAP SYNDROME 1 3 2 8 
                            TOTAL 31 100 24 100 
 
 
 
  
SEX RATIO FOR INDIVIDUAL COLLAGEN VASCULAR DISORDERS: 
 
                                TYPES                 SEX RATIO (M:F) 
                RHEUMATOIDARTHRITIS 1:2 
                SYSTEMIC SCLEROSIS 3:2 
  SYSTEMIC LUPUS ERYTHEMATOSUS 1:4 
                POLYMYOSITIS/DERMATOMYOSITIS 1:3 
SJOGRENS SYNDROME 1:1 
OVERLAP SYNDROME 2:1 
 
 
CLINICAL FEATURES: 
                                 
                           The pulmonary symptoms most commonly presented were non 
productive cough, breathlessness, chest pain and haemoptysis. Of this 
nonproductive cough was present in 49 patients (89.09%) followed by 
breathlessness in 41 patients (74.54%), chest pain in 17 patients (30.9%) 
and 4 patients (7.27%) with haemoptysis (Fig 3).  
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              Fig 3.   Pulmonary symptoms observed in the Interstitial lung diseases  patients. 
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 Fig 4.  Aetiological classification of Interstitial lung diseases of collagen vascular   
disorders.      
       
 
PULMONARY SYMPTOMS: 
 
COLLAGEN VASCULAR DISORDERS 
Systemic 
sclerosis  
Rheumatoid 
Arthritis 
Systemic Lupus 
Erythematosus 
Sjogrens 
syndrome 
Polymyositis/ 
Dermato- 
-myositis 
Overlap 
syndrome 
 
Symptoms 
No. % No. % No. % No. % No. % No % 
Dry Cough  19 95   18 94.7   3 60  3 75   4 100  2 66.7 
Dyspnoea  17 85   14 73.7   4 80  3 75   2 50  1 33.3 
Chest pain   4 20    7 36.8   3 60  1 25   1 25  1 33.3 
Haemoptysis   -     1 5.3   2 40  1 25    -    -  
 
The predominant symptom found in majority of the study cases is 
nonproductive cough followed by breathlessness, chest pain and 
haemoptysis. 
 
EXTRA PULMONARY SYMPTOMS: 
  Dyspepsia / Dysphagia / Raynauds phenomenon. 
  Inflammatory arthritis / subcutaneous nodules. 
  SICCA syndrome. 
  Skin lesions like rashes, discolouration and thickening . 
   Proximal muscle weakness. 
These above mentioned extra pulmonary symptoms which is 
present concomitantly in our cases and these symptoms have preceded or 
accompanied with the respiratory illness.  
 
 
 Frequency Percent Valid Percent Cumulative Percent
 
DM/PM 4 7.3 7.3 7.3 
 
MCTD 3 5.5 5.5 12.7 
 
RA 19 34.5 34.5 47.3 
 
SJO 4 7.3 7.3 54.5 
 
SLE 5 9.1 9.1 63.6 
 
SS 20 36.4 36.4 100.0 
 
 
Total 55 100.0 100.0  
   
                               
Rheumatoid arthritis and systemic sclerosis forms the bulk of the 
study population. It constitutes more than 70 % of the cases. Followed by 
5 cases of Systemic lupus erythematosus and 4 cases each from 
Sjogrens syndrome and Dermato myositis / Polymyositis respectively and 
3 cases from Mixed connective tissue disorder (Fig 4). 
 
 
                           Chest x-ray showed parenchymal abnormalities only in 32 patients 
(58.18%) who had evidence of fibrosis on High resolution computerized 
tomography. Parenchymal abnormalities are in the form of reticular, 
nodular, reticulonodular and patchy ground glass opacity. 
 
  Cross tabulation of the chest x-ray and High resolution 
computerized tomography was done and their relationship were 
statistically analysed. Chest x-ray showed low sensitivity in diagnosing 
DPLD (diffuse parenchymal lung diseases) when compared to high 
resolution computerised tomogram. The efficiency of the chest x-ray is 
58%. Though specificity is 98% the sensitivity is very low and marks only 
58%. The kappa value is 0 indicating the discordance between chest x-ray 
and high resolution computerized tomogram in diagnosing ILD cases and 
the McNemar  test showing the p value more than 0.05 indicating that 
there is no significant association. 
 
COLLAGEN VASCULAR DISORDERS  
 
HRCT 
patterns 
 
Systemic 
sclerosis  
 
Rheumatoid 
Arthritis 
 
Systemic Lupus 
Erythematosus 
 
Sjogrens 
syndrome 
 
Polymyositis/ 
Dermato- 
-myositis 
 
Overlap 
syndrome 
Reticular 19 18 3 4 4 2 
Ground 
glass opacity  
(GGO) 
 
1 
 
1 
 
2 
 
- 
 
- 
 
1 
Total 20 19 5 4 4 3 
  
              
 
Fig5.  Inter and Intra lobar septal thickening with traction bronchiectasis. 
 
 
 
 
      
Fig 6.  Bilateral sub pleural thickening and traction bronchiectasis more on the  
                right side. 
 
Reticular 50 
Ground glass 
opacity (GGO) 
 5 
Total 55 
 
 
                                   The frequently observed High resolution 
computerized tomography pattern is reticular (91%) (Fig 5, 6) and other is 
Ground Glass Opacity (9%) (Fig7,8). The profusion of lesion is variable 
but it predominated in the lower zone.  
 
SITE OF LESION NUMBER PERCENTAGE 
Lower zone 55 100 
Mid and lower 26 47.27 
Upper, Mid and Lower zone 7 12.73 
HRCT Vs PFT
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Fig 7. Bilateral diffuse Ground glass opacity. 
 
 
 
 
  
Fig 8.  Bilateral diffuse Ground glass opacity. 
 
 
 
                       HRCT (Reticular pattern) versus PFT (FVC)  
 High 
resolut
RETICULAR PATTERN 
TYPES No. PERCENTAGE 
Forced Vital Capacity (FVC) is uniformly reduced in both the
ion computerized tomography patterns. Mean of FVC in reticular 
pattern is 2.54L with standard deviation of 0.175 (2.54±0.35). Similarly in 
Ground Glass Opacity pattern, the mean is 3.008L with standard deviation 
of 0.18 (3.008±0.36). Reticular pattern of High resolution computerized 
tomography is compared with the pulmonary function parameter of Forced 
Vital Capacity by using MIR SPIROLAB (Fig.10). The correct classification 
(efficiency) of the test is found to be 93%. The sensitivity is 90% and the 
specificity is 98%. Kappa score is 0.82 and p value is less than 0.001 
indicating a good agreement. By McNemar test: p <0.001 also a indicator 
of perfect agreement.  
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              Fig 9.  Honey combing – indicates the advanced stage of Interstitial lung diseases. 
 
 
 
 
 
 
 
 Fig10. MIR SPIRO LAB used for assessing the Pulmonary Functions.  
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HRCT (Reticular pattern) vesus BAL (Neutrophils) 
 
Abnormal differential cell counts (alveolitis) at bronchoalveolar 
lavage were found in (76.66%) of the study group. Following types of 
alveolitis were found, pure lymphocytic, pure neutrophilic and mixed 
cellularity or with normal patterns. From the Bronchoalveolar lavage 
cellularity it is inferred that neutrophils and lymphocytes forms the bulk 
(70%) of the study (Fig.11&12) and almost equal contribution from each 
(35%). Reticular pattern of high resolution computerized tomography is 
compared with neutrophilic cellularity and statistically analysed. The 
correct classification (efficiency) of the test is found to be 98%. Sensitivity 
is 95% and specificity is about 97%. Kappa score of about 0.95 and p 
value less than 0.001 indicating a very good agreement.  
 
  
BAL DIFFERENTIAL COUNT
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Normal Neutrophil Lymphocytic mixed
Fig11.  Differential cell count of Bronchoalveolar lavage fluid. 
 
 
 
Fig12. Predominant neutrophils seen in the Bronchoalveolar lavage fluid. 
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          The cellularity of Bronchoalveolar fluid identified from all the 
cases of Sjogrens syndrome is found to be lymphocytic predominance. 
 
 
 
 
 
 
 
DISCUSSION 
The study  principally focuses on the characterization of the pattern 
and profusion of the radiological lesions and its severity is analysed by 
comparing with the pulmonary function (Forced vital capacity) and the 
cellularity of Bronchoalveolar lavage fluid. 
 
Slight female predominance is noted in the incidence of Interstitial 
lung Diseases among collagen vascular disorder patients. The sex ratio 
favours female in systemic lupus erythematosus by 4 folds. MasiAt et al 
studied the sex effects in systemic lupus erythematosus-a clue to the 
pathogenesis published in Arthritis Rheum found to be 10 fold increase in 
the female sex incidence. Similarly females outnumber males in 
polymyositis / dermatomyositis and rheumatoid arthritis. The sex ratio is 
1:3 and 1:2 respectively. It favours male sex in overlap syndrome and 
systemic sclerosis. The ratio is equal in sjogrens syndrome (1:1). There is 
not of much significant difference in sex wise age distribution as identified. 
 
                                           On the other hand comparing the chest 
x-ray with high resolution computerized tomography in our study, chest x-
ray showed parenchymal abnormalities in (58.18%) who had evidence of 
fibrosis on High resolution computerized tomography. Abnormal 
differential cell counts (alveolitis) at bronchoalveolar lavage were found in 
(76.66%). Following types of alveolitis were found, pure lymphocytic, pure 
neutrophilic, mixed cellularity and with normal patterns.  
A study by Salaffi F and co workers about subclinical interstitial 
lung involvement in rheumatic diseases in which they correlated high 
resolution computerized tomography with functional and cytologic findings. 
Results of that Italian study indicates that the chest X-ray showed 
parenchymal abnormalities in only 15 patients (18.7%) who had evidence 
of fibrosis on High resolution computerized tomography. Abnormal 
differential cell counts (alveolitis) at bronchoalveolar lavage were found in 
(57.5%). Three types of alveolitis were observed: pure lymphocyte 
alveolitis, pure neutrophil alveolitis, and neutrophil alveolitis associated 
with lymphocytosis (mixed alveolitis). Patients with neutrophil alveolitis 
had more extensive disease on High resolution computerized tomography 
than those with lymphocyte alveolitis or with normal cellular patterns at 
bronchoalveolar lavage. The extent of a reticular pattern on High 
resolution computerized tomography correlated with the neutrophil of 
Bronchoalveolar lavage.  
 Hence it is inferred from the study that the High resolution 
computerized tomography is a highly sensitive tool in diagnosing 
Interstitial lung diseases (ILD /DPLD) of Collagen vascular disorder 
patients when compared to chest x ray. Predominant High resolution 
computerized tomography pattern identified from our study is Reticular 
rather than Ground glass opacity.    
                                            Neutrophilic cellularity of Bronchoalveolar lavage(BAL) is 
predominant in reticular pattern of High resolution computerized 
tomography and correlated well. Thereby it can predict the prognosis, as 
the response to steroids is weaker compared to the lymphocytic cellularity 
which is studied by Keith C Meyer et al and published in clin chest med 
sep 2004. All cases of Sjogrens syndrome had lymphocytic cellularity in 
Bronchoalveolar lavage suggestive of Lymphocytic interstitial pneumonitis.  
Lower zone lesions are observed in majority of the cases compared 
to the mid and upper zones. Septal thickening is more frequently seen 
than honey combing. Irrespective of the High resolution computerized 
tomography pattern, most of them had reduced vital capacity. But the 
severity of reduction in Forced Vital Capacity is significant in Reticular 
compared to GGO(Ground Glass Opacity) pattern. 
 
  Bronchoalveolar lavage is broadly indicated in every patient with 
unclear diffuse lung disease. Nevertheless, Bronchoalveolar lavage has 
several advantages over biopsy procedures. It is safe and associated with 
virtually no morbidity. It collects sample from much larger area of the lungs 
than possible with biopsies. Hence it gives a representative picture of both 
inflammatory and immunological changes at an earlier date. So 
Bronchoalveolar lavage can be used as an adjunct along with clinical and 
radiological parameters in narrowing the differential diagnosis. 
CONCLUSION 
  Majority of the cases (91%) were presented with the reticular 
pattern compared to the Ground Glass Opacity. 
           Both High resolution computerized tomography patterns (Reticular 
and Ground glass opacity) have reduced vital capacity but the severity of 
reduction is more in reticular pattern than that of the Ground Glass 
Opacity. 
           Of the reticular pattern inter / intralobar septal thickening is more 
frequent than either honey combing or sub pleural thickening. 
           The presence of Reticular pattern in High resolution computerized 
tomography has a very good correlation with reduced Forced vital capacity 
of the Pulmonary function test.                                                                                                  
           From the cross tabulation listed above and analyzing the Reticular 
pattern of high resolution computerized tomography with neutrophilic 
cellularity of Bronchoalveolar lavage, it is inferred from the values that 
there is a perfect agreement between these both. 
           Similarly the Ground Glass Opacity pattern has positive correlation 
with lymphocytic cellularity of Bronchoalveolar lavage.  
 So High Resolution Computerised Tomography is a sensitive tool in 
identifying pattern and profusion of the lesion. The severity of the lesion is 
identified by correlating High Resolution Computerised Tomography, 
pulmonary function and Bronchoalveolar lavage. 
 
 
ABBREVIATIONS: 
 
AIIP   Acute Idiopathic Interstitial Pneumonitis 
BAL   Broncho Alveolar Lavage 
BOOP  Brochiolitis Obliterans Organising pneumonia 
CTD   Connective Tissue Disorders 
DIP   Diffuse Interstitial Pneumonitis 
 
HRCT  High Resolution Computerised Tomography 
ILD   Interstitial Lung Diseases 
LIP   Lymphocytic Interstitial Pneumonitis 
NSIP   Non Specific Interstitial Pneumonitis 
OP   Organising pneumonia 
PFT   Pulmonary Function Test 
RA   Rheumatoid Arthritis 
RBILD  Respiratory Bronchiolitis Interstitial Lung Diseases 
SLB   Surgical Lung Biopsy 
TBLB  Trans Bronchial Lung Biopsy 
UIP   Usual Interstitial Pneumonitis 
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MASTER CHART 
NAME AGE SEX
HRCT 
PAT 
FVC(L)& 
% OF PRED 
FEV1/FVC 
(%) BAL DIAGNOSIS
JEEVA 38 M R 2.24(62%) 84 L SS 
PADMAVATHY 45 F R 1.78(48%) 93 N SS 
LAKSHMIPATHY 45 M R 2.67(64%) 101 M RA 
TIRUPURASUNDARI 40 F R 2.45(61%) 66 L RA 
HARIDOSS 42 M R 1.9(52%) 91 M SS 
VILVAKUMAR 54 M R 2.11(54%) 82 NOR RA 
KALAISELVI 30 F R 2.98(87%) 76 L RA 
EZHIL ARASI 45 F R 2.52(56%) 106 N RA 
DEVI  32 F R 1.61(49%) 111 N SS 
MURUGESAN 45 M R 2.53(58%) 59 L SS 
MUNIAMMA 41 F R 2.42(54%) 102 N SLE 
SAROJA 36 F R 1.71(40%) 86 NOR RA 
VIJAYAKUMAR 30 M R 2.29(56%) 83 N SLE 
DAMODHARAN 47 M R 2.46((53%) 98 N SS 
CHANDRAMMA 32 F R 2.64(50%) 94 M SS 
JAGADEESAN 31 M R 1.43(44%) 97 M SS 
KASTURI 27 F R 1.66(48%) 61 N RA 
PONNUTHAI 39 F R 2.02(53%) 95 NOR RA 
VELU 43 M R 2.35((56%) 107 L RA 
LAKSHMIPATHY 51 M R 2.82(63%) 74 NOR DM/PM 
RAJESWARI 43 F R 1.92(51%) 89 L RA 
CHINNAYA 37 M R 1.8(46%) 93 NOR SS 
NAVANEETHAM 45 F G 2.78(74%) 97 M SLE 
KUMARI 24 F R 3.32(81%) 104 L SS 
SANKAR 29 M R 3.67(72%) 63 N SS 
GUHAN 31 M R 2.94(66%) 86 N SS 
BARATHI 37 F R 3.04(69%) 93 N RA 
MAHESWARAN 41 M R 2.85(58%) 48 L SS 
ANANDHI 25 F R 2.39(59%) 102 NOR RA 
SAMPATH 33 M R 3.52(69%) 106 M SS 
MANIMEGALAI 28 F R 2.84(57%) 96 M SLE 
GOWRI SANKAR 42 M G 2.67(54%) 110 L RA 
KOMALAVALLI 44 F R 2.48(51%) 107 L RA 
USHA 39 F R 3.31(68%) 94 NOR SS 
GOPAL 31 M G 3.49(83%) 103 L SS 
THILAGAVATHI 26 F R 3.39(69%) 95 L DM/PM 
RAMANI 37 F R 2.89(63%) 88 NOR SS 
MALLIGA 19 F R 2.78(61%) 73 L DM/PM 
SENTHIL 36 M R 2.35(57%) 63 N MCTD 
EZHIL ARASI 40 F G 2.34(51%) 87 M SLE 
NANDAKUMAR 31 M R 2.63(63%) 81 N RA 
LEELAVATHY 46 F R 2.07(56%) 59 N RA 
KRISHNAN 40 M G 3.76(84%) 94 L MCTD 
VIMALA 37 F R 1.78(40%) 86 N SS 
JAYANTHI 26 F R 2.81(62%) 113 N DM/PM 
DEEPA 23 F R 3.33(68%) 78 L SJO 
THAMILSELVI 34 F R 2.45(64%) 89 N RA 
CHEVVEL 48 M R 3.18(67%) 52 L SJO 
SEETHALAKSHMI 39 F R 2.82(58%) 124 L RA 
VALARMATHY 47 F R 1.61(39%) 73 M MCTD 
CYNTHIA 35 F R 2.23(57%) 85 L SJO 
KARTHICK 29 M R 3.48(84%) 96 N RA 
PARVATHY 50 F R 2.31(54%) 105 N SS 
SABAPATHY 41 M R 2.85(59%) 47 N SS 
KUMAR 27 M R 3.21(68%) 84 L SJO 
 
